Vistagen Therapeutics Inc (VTGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VTGN | AZN | AMGN | GILD | VRTX |
| Company | Vistagen Therapeutics Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 4.51 | 91.18 | 316.25 | 119.49 | 438.81 |
| High | 4.54 | 91.30 | 316.97 | 120.10 | 441.03 |
| Low | 4.41 | 90.16 | 313.00 | 118.78 | 433.81 |
| Latest | 4.51 | 89.94 | 316.46 | 119.97 | 436.12 |
| Change | -0.04 | +0.12 | +2.61 | +0.61 | -0.89 |
| % Change | -0.88% | +0.13% | +0.83% | +0.51% | -0.20% |
| Volume | 111,249 | 1,562,100 | 521,902 | 1,136,701 | 143,010 |
| 20-Day Average Volume | 922,117 | 5,336,328 | 2,811,823 | 6,855,855 | 1,351,799 |
| Previous Close | 4.55 | 89.82 | 313.85 | 119.36 | 437.01 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 4.34 | 90.36 | 335.89 | 124.38 | 435.68 |
| 20-Day Raw Stochastic | 61.80% | 47.90% | 6.17% | 9.07% | 35.87% |
| 20-Day Relative Strength | 53.97 | 58.39 | 46.18 | 45.62 | 52.68 |
| Weighted Alpha | +84.16 | +39.21 | +16.20 | +26.69 | -3.74 |
| Today's Opinion | 96% Buy | 100% Buy | 72% Buy | 56% Buy | Hold |
| Previous Opinion | 96% Buy | 88% Buy | 72% Buy | 56% Buy | 24% Buy |
| Last Month's Opinion | 88% Buy | 100% Buy | 56% Buy | 88% Buy | 24% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +19.57% since 12/03/25 | -0.41% since 12/03/25 | -8.76% since 12/03/25 | -4.26% since 12/03/25 | -6.12% since 12/03/25 |
| Low | 3.74 on 12/04/25 | 89.67 on 12/08/25 | 313.10 on 12/10/25 | 118.78 on 12/10/25 | 433.81 on 12/10/25 |
| High | 4.60 on 12/09/25 | 91.44 on 12/09/25 | 346.33 on 12/04/25 | 124.96 on 12/04/25 | 463.70 on 12/04/25 |
| 1-Month | |||||
| %Chg | +12.06% since 11/10/25 | +3.43% since 11/10/25 | -2.63% since 11/10/25 | +1.29% since 11/10/25 | +3.23% since 11/10/25 |
| Low | 3.36 on 12/03/25 | 87.23 on 11/12/25 | 313.10 on 12/10/25 | 118.58 on 11/11/25 | 417.12 on 11/11/25 |
| High | 5.14 on 11/24/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 3-Month | |||||
| %Chg | +24.93% since 09/10/25 | +11.97% since 09/10/25 | +13.16% since 09/10/25 | +3.84% since 09/10/25 | +11.90% since 09/10/25 |
| Low | 2.84 on 09/16/25 | 72.89 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 374.17 on 09/24/25 |
| High | 5.14 on 11/24/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 6-Month | |||||
| %Chg | +86.61% since 06/10/25 | +22.55% since 06/10/25 | +7.40% since 06/10/25 | +8.71% since 06/10/25 | -3.71% since 06/10/25 |
| Low | 1.94 on 06/23/25 | 68.61 on 07/21/25 | 267.83 on 06/23/25 | 104.46 on 06/25/25 | 362.50 on 08/11/25 |
| High | 5.14 on 11/24/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 484.56 on 07/10/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 179,702 | 278,570,080 | 169,002,272 | 148,087,568 | 110,877,744 |
| Shares Outstanding, K | 39,495 | 3,101,426 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 490,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -51,420,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 260,000 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | -19,420,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | 0.56 | 0.32 | 0.45 | 0.32 | 0.32 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.54 on 11/13/25 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 02/12/26 | 02/05/26 | 02/03/26 | 02/10/26 | 02/09/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 09/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 08/08/25 | 11/21/25 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.97 | 14.69 | 14.80 | 28.87 |